CA
REGN icon

Commerzbank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-38,800
Closed -$1.37M – 996
2019
Q2 		$1.37M Buy
+38,800
New +$12.9M 0.01% 541
2018
Q1 		– Sell
-30,000
Closed -$2K – 1014
2017
Q4 		$2K Buy
30,000
+29,200
+3,650% +$11.8M ﹤0.01% 941
2017
Q3 		$358K Buy
+800
New +$381K ﹤0.01% 675

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Commerzbank Aktiengesellschaft's REGN Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 6.7% in Q1 2026, selling an estimated $29.9K and leaving 539 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #277.

Commerzbank Aktiengesellschaft first reported a position in REGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $33.9M in Q2 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Commerzbank Aktiengesellschaft held 539 shares of Regeneron Pharmaceuticals worth $416K as of Q1 2026.
  • Commerzbank Aktiengesellschaft sold 39 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $29.9K.
  • Regeneron Pharmaceuticals made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #277 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
  • Commerzbank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $33.9M in Q2 2015.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.